{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:05:15Z","timestamp":1793196315561,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jacadv.2023.100818","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:01:36Z","timestamp":1707919296000},"page":"100818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"P2","title":["Determinants of Guideline-Directed Medical Therapy Implementation During Heart\u00a0Failure Hospitalization"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-3072","authenticated-orcid":false,"given":"Emily","family":"Margolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Brann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jacadv.2023.100818_bib1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"Hunt","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.jacadv.2023.100818_bib2","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jacadv.2023.100818_bib3","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100818_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cjca.2021.01.017","article-title":"CCS\/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100818_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacadv.2023.100818_bib6","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10175","key":"10.1016\/j.jacadv.2023.100818_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","article-title":"Heart failure drug treatment","volume":"393","author":"Rossignol","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jacadv.2023.100818_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","article-title":"Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation","volume":"67","author":"Roth","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2023.100818_bib9","first-page":"561","article-title":"Treatment initiation patterns, Modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis","volume":"22","author":"Deschaseaux","year":"2016","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"16","key":"10.1016\/j.jacadv.2023.100818_bib10","article-title":"Real-World analysis of guideline-based therapy after hospitalization for heart failure","volume":"9","author":"Wirtz","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100818_bib11","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","article-title":"Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study","volume":"8","author":"Tromp","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10.1016\/j.jacadv.2023.100818_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003552","article-title":"National differences in Trends for heart failure hospitalizations by sex and race\/ethnicity","volume":"10","author":"Ziaeian","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.jacadv.2023.100818_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007264","article-title":"Understanding the complexity of heart failure risk and treatment in black patients","volume":"13","author":"Nayak","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100818_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1751-7133.2011.00263.x","article-title":"Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart\u00a0Failure Adherence Retention Trial (HART)","volume":"18","author":"Calvin","year":"2012","journal-title":"Congest Heart Fail"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100818_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2010.03.043","article-title":"Cardiac performance measure compliance in outpatients: the American College of Cardiology and national cardiovascular data registry's PINNACLE program","volume":"56","author":"Chan","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100818_bib16","article-title":"Contemporary reevaluation of race and ethnicity with outcomes in heart failure","volume":"10","author":"Savitz","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100818_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchf.2022.08.023","article-title":"Treatment differences in medical therapy for heart failure with reduced ejection fraction between sociodemographic groups","volume":"11","author":"Witting","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"19","key":"10.1016\/j.jacadv.2023.100818_bib18","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1001\/jama.289.19.2517","article-title":"Race, quality of care, and outcomes of elderly patients hospitalized with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jacadv.2023.100818_bib19","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2011.02.322","article-title":"Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients","volume":"107","author":"Krantz","year":"2011","journal-title":"Am J Cardiol"},{"issue":"Suppl 3","key":"10.1016\/j.jacadv.2023.100818_bib20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s11606-022-07595-1","article-title":"Gender differences in guideline-directed medical therapy for cardiovascular disease among young veterans","volume":"37","author":"Dhruva","year":"2022","journal-title":"J\u00a0Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jacadv.2023.100818_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jchf.2022.03.009","article-title":"Effects of dapagliflozin according to the heart failure collaboratory medical therapy score: insights from DAPA-HF","volume":"10","author":"Butt","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.jacadv.2023.100818_bib22","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart\u00a0Failure Collaboratory and Academic Research Consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"10367","key":"10.1016\/j.jacadv.2023.100818_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure: a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jacadv.2023.100818_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100818_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacadv.2023.100818_bib26","author":"Mehrotra"},{"issue":"20","key":"10.1016\/j.jacadv.2023.100818_bib27","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.jacadv.2023.100818_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.jacc.2018.02.077","article-title":"Cardiovascular disease and homelessness","volume":"71","author":"Baggett","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacadv.2023.100818_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000089","article-title":"Importance of housing and cardiovascular health and well-being: a scientific statement from the American Heart Association","volume":"13","author":"Sims","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23008669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23008669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:42:54Z","timestamp":1740174174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X23008669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2772963X23008669"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100818","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of Guideline-Directed Medical Therapy Implementation During Heart\u00a0Failure Hospitalization","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100818"}}